Healthcare · Operations & Throughput
Automate Finance Back Office in Medical Devices with AI
We design, build, and run AI-native finance back office for medical device manufacturers, field service leaders, quality teams, and commercial operations. This page describes the engagement: scope, pricing, timeline, controls, and the KPIs we commit to.
Early access: we work with a small first cohort. Engagements are scoped, priced, and shipped end-to-end by our team — not referred to third parties.
In one sentence
AI-native finance back office for medical devices is a phased engagement (Discovery 2.5 weeks → Build 7 weeks → Run continuous) that ships a production workflow on top of QMS and CRM, moves close cycle time by −75% against the medical devices baseline, and is operated under operations & throughput governance from day one.
Key facts
- Industry
- Medical Devices
- Use case
- Finance Back Office
- Intent cluster
- Operations & Throughput
- Primary KPI
- close cycle time, exception rate, invoice processing cost, and forecast variance
- Top benchmark
- Time-to-onboard new operator: 8 weeks → 2 weeks (−75%)
- Systems integrated
- QMS, CRM, field service platforms
- Buyer
- medical device manufacturers, field service leaders, quality teams, and commercial operations
- Risk lens
- quality management, clinical claims, product support, training accuracy, and complaint handling
- Engagement timeline
- Discovery 2.5 weeks → Build 7 weeks → Run continuous
- Team size
- 2 senior delivery (1 architect + 1 implementer)
- Discovery price
- $6k · 2-week sprint
- Build price
- $20k–$28k · 6-10 weeks
Primary outcome
reduce manual finance work without losing control
What we ship
invoice workflows, reconciliation assistant, variance explanations, and approval controls
KPIs we report on
close cycle time, exception rate, invoice processing cost, and forecast variance
Why Medical Devices teams hire us for this
What separates AI-native finance back office from "AI features added on top" is operating discipline. The pattern that works in medical devices is the same one that works for any high-stakes operational system: instrument the baseline, ship a thin slice to production, govern explicitly, then expand. We run every engagement against that pattern.
Operations benchmarks across medical devices typically show 20-35% of operator time absorbed by status checks, handoffs, and exception triage. AI-native automation reclaims that block first because it has the highest volume and lowest decision risk.
Industry context: Mid-market and enterprise operators face the same fundamental tradeoff: AI must compress operational cycle time while remaining auditable and integrable with existing systems of record.
Benchmarks we hit
Reference benchmarks from production deployments of finance back office in medical devices-comparable contexts. Sources noted per row. Your actuals are measured against the baseline captured in Discovery.
| Metric | Industry baseline | AI-native typical | Delta |
|---|---|---|---|
Time-to-onboard new operator AI assistant handles the long tail of edge cases that previously required senior coaching | 8 weeks | 2 weeks | −75% |
Cycle time per transaction Measured on labelled production samples; excludes outliers >2σ | 47 min median | 8 min median | −83% |
Error rate on repeatable steps Quality control sampling; AI-native gates catch errors before downstream propagation | 6.1% | 1.4% | −77% |
Benchmarks are reference values from comparable engagements and authoritative sector benchmarks. Your engagement's baseline is captured during Discovery and actuals are reported weekly during Run against that baseline.
How we operate the workflow
Medical Devices buyers often ask whether they can keep their existing tooling stack. The answer is almost always yes — we build the AI-native operating layer on top of QMS and the surrounding systems, not as a replacement. The integration surface is scoped in Discovery and capped in the Build statement of work, so the engagement does not turn into a re-platforming.
What we build inside the workflow
The Build phase for finance back office in medical devices produces six tangible artefacts: a workflow map (current and target state), a labelled test set (200-1000 cases minimum), a prompt and retrieval repository (versioned, tested, deployed), the integration layer (against QMS and adjacent systems), the reviewer queue (with SLAs and escalation paths), and the operating dashboard (KPIs, drift detection, attestation pack). All six are inspectable, all six are handed over.
Reference architecture
4-layer AI-native workflow for operations & throughput
Source intake → AI orchestration → Action → Human review & quality.See the full architecture diagram for Operations & Throughput →
AI-native vs traditional approach
How a scoped AI-native engagement compares to the traditional alternatives for finance back office in medical devices.
| Dimension | Traditional (in-house build or BPO) | AI-native engagement (us) |
|---|---|---|
| Time to production | 6-12 months | 6-10 weeks (thin slice) |
| Pricing model | FTE hourly retainer or fixed staffing | Phased fixed-price (Discovery → Build → opt Run) |
| Audit / governance | Manual logs, periodic review | Versioned prompts, audit logs, reviewer queues, attestations |
| Operator throughput lift | 1.0× (baseline) | −83% |
| Cost per unit | Industry baseline | AI-native engagements deliver thin-slice production in 6-8 weeks with measurable baseline-vs-actuals reporting. |
| Exit path | Multi-quarter notice + knowledge loss | Month-to-month Run, full handover plan in Build SoW |
Traditional process automation projects cost $80-200k+ with 6-12 month payback; AI-native engagements deliver thin-slice production in 6-8 weeks with measurable baseline-vs-actuals reporting.
Engagement scope & pricing
We run this as a fixed-scope engagement with a clear commercial envelope, not an open-ended retainer.
Operations engagement
Three phases, billed separately. You commit one phase at a time.
Phase 1 · Discovery
$6k
2-week sprint
Phase 2 · Build
$20k–$28k
6-10 weeks
Phase 3 · Run
$2.5k–$4k / mo
optional, hourly bank also available
~$32k–$58k typical year 1 (60% take the run option for ~6 months)
Workflow redesign, system integration, governance, and weekly operating cadence during Run.
Discovery is the only commitment to start. After Discovery, we scope Build with a fixed price. Run is opt-in, month-to-month, no lock-in.
The 4-phase delivery model
Phase 1 · Weeks 1–2
Discovery
We map the workflow, the systems, the decisions, and the baseline metrics. Output: a scoped statement of work.
Phase 2 · Weeks 2–4
Design
We design the operating model: data access, retrieval, prompts, review queues, controls, and the KPI dashboard.
Phase 3 · Weeks 4–8
Build
We ship a production thin slice on real data, with versioned prompts, evaluation harness, and human review.
Phase 4 · Weeks 8+
Run
We run the workflow with you weekly, expand into adjacent work, and report against baseline.
Interactive ROI calculator
Estimate your AI-native ROI for finance back office
Reference inputs below are typical for medical devices teams in the operations cluster. Adjust them to match your situation.
Projected
Current monthly cost
$56,000
AI-native monthly cost
$18,520
Annual savings
$449,760
67% cost reduction · ~2,601 operator-hours freed / month
Governance and risk controls
The hardest governance question in AI-native delivery is not "how do we audit?" — it is "what cases do we route to humans?". For medical devices workflows touching quality management, clinical claims, product support, training accuracy, and complaint handling, we set explicit confidence thresholds during Build, validate them against the labelled test set, and recalibrate weekly during Run. Reviewers see only the cases that need them, with the supporting evidence pre-assembled.
How we report ROI
ROI conversations on finance back office usually start with "how much will it save?" and stall there. We reframe them around three measurable shifts: throughput per operator, time per case, and quality variance — all benchmarked against the Discovery baseline. Once those shifts are documented, the cost-per-transaction conversation answers itself.
Common pitfall & mitigation
The failure mode we see most often on AI-native finance back office engagements in medical devices contexts.
Operator distrust
Senior operators reject AI suggestions silently, throughput stagnates
Co-design with 2-3 senior operators during Build; their feedback shapes confidence thresholds
Build internally or work with us
The opportunity cost of building first in medical devices is often invisible: 6-9 months spent hiring, tooling, and converging on a reference architecture is 6-9 months of competitors shipping. The engagement model we propose front-loads the reference architecture and the senior delivery team, then transitions the operation to your team once the pattern is proven.
What to ask us before signing
- Ask for a workflow map that shows intake, retrieval, generation, review, escalation, system updates, and measurement.
- Ask for an evaluation plan using real examples from medical devices, not only generic test prompts.
- Ask how we will move close cycle time, exception rate, invoice processing cost, and forecast variance within the first 30 to 60 days.
- Ask which parts of the process remain human-owned and why.
- Ask for our exit plan: what stays with you if the engagement ends.
Recommended first project
The best first project for AI-native finance back office in medical devices is a contained workflow with enough volume to matter and enough structure to evaluate. Avoid the most politically sensitive process first. Avoid a workflow with no measurable baseline. Choose a process where we can ship a production-grade thin slice, prove adoption, and then extend the same architecture to neighboring work.
A practical target is a 30-day build followed by a 60-day operating period. In the first 30 days, we map the work, connect the minimum data sources, build the assistant, and create the review process. In the next 60 days, the system handles real volume, the team measures outcomes, and we improve the workflow weekly. By day 90, leadership knows whether to expand into adjacent work.
Frequently asked questions
How do you automate finance back office in medical devices with AI?+
We map the existing finance back office workflow inside medical devices, identify the high-volume, high-structure tasks, and build an AI agent that handles those tasks while routing low-confidence cases to a human reviewer. The build connects to your QMS, CRM, field service platforms, runs against a labelled test set, and ships behind a reviewer queue before it sees production traffic. We then operate it, measure close cycle time, exception rate, invoice processing cost, and forecast variance, and improve it weekly.
What does it cost to automate finance back office for a medical devices company?+
Three phases, billed separately. Discovery sprint: $6k (2-week sprint). Build engagement: $20k–$28k (6-10 weeks). Run retainer: $2.5k–$4k / mo (optional, hourly bank also available). ~$32k–$58k typical year 1 (60% take the run option for ~6 months). Workflow redesign, system integration, governance, and weekly operating cadence during Run.
What is the best AI agent for finance back office in medical devices?+
There is no single "best" off-the-shelf agent for finance back office in medical devices — the right architecture depends on your QMS setup, your data, and your risk profile. We typically combine a frontier LLM (Claude, GPT-4-class, or Gemini) with a retrieval layer over your approved sources, tool-use for QMS and CRM integrations, and a reviewer queue. We benchmark candidate models against a labelled test set during Discovery and pick the one with the best accuracy/cost ratio for your workflow.
How long does it take to deploy AI finance back office for medical devices?+
A thin-slice deployment in 2-week sprint after Discovery, with real medical devices data and real reviewers. The full Build phase runs 6-10 weeks. By day 90, close cycle time, exception rate, invoice processing cost, and forecast variance is instrumented, the team has a baseline, and leadership has the data needed to decide on expansion into adjacent medical devices workflows.
What do we own, and what do you own?+
We own the workflow design, the prompts, the retrieval architecture, the evaluation harness, and weekly improvement. Your medical device manufacturers, field service leaders, quality teams, and commercial operations team owns data access, policy, exception approval, and final commercial decisions. At the end of the engagement, every prompt, eval, and config is handed over — no lock-in.
How fast does AI finance back office get into production for medical devices?+
We aim for a thin-slice in production by week 6, with real data, real edge cases, and real reviewers. close cycle time, exception rate, invoice processing cost, and forecast variance is instrumented from day one, and we report against baseline weekly during Run.
Sources we reference
The following sources inform the architecture, governance, and benchmarks we apply on medical devices engagements. Cited here so you can verify and dig deeper.
- FDA Digital Health
- Hype Cycle for Artificial Intelligence — Gartner
- MIT Sloan Management Review — AI & Business Strategy — MIT Sloan
- Future of Work: Operations — Deloitte Insights
- Lighthouse Network — Operations AI Adoption — World Economic Forum + McKinsey
- Google Search Central: helpful, reliable, people-first content
- Google Search Central: URL structure best practices
Concepts on this page:
AI workflow·Thin slice·Reviewer queue·Evaluation harness·Tool use·Audit logFull glossary →Start the engagement
Book a discovery call for Medical Devices
Tell us about your workflow, the systems involved, and the KPI you want to move. We'll send a scoped statement of work within 5 business days.